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Abstract
Introduction
Genetic testing remains low among racial/ethnic minority 
populations in the United States. We aimed to determine 
the  prevalence  and  correlates  of  awareness  of  direct-
to-consumer  (DTC)  genetic  tests  and  the  prevalence  of 
genetic test use in a population-based sample of adults in 
Puerto Rico.
Methods
We analyzed data from adults aged 18 years or older who 
completed information on genetic test awareness (n = 611; 
96%  of  study  population)  from  the  Health  Information 
National Trends Survey conducted in Puerto Rico in 2009. 
Odds ratios with 95% confidence intervals were estimated 
by using logistic regression models to identify factors asso-
ciated with awareness of DTC genetic tests.
Results
The majority of respondents (56%) were aware of direct-
to-consumer genetic tests, and approximately 4% had ever 
undergone any genetic test. Respondents who had never 
been married were less likely to be aware of DTC tests, 
as were current smokers. Respondents who ever sought 
cancer information were more likely to be aware of these 
tests.
Conclusion
We provide the first published data on the awareness of 
DTC genetic tests and on use of genetic testing in Puerto 
Rico.  Forty-four  percent  of  our  sample  of  Puerto  Rican 
adults were unaware of direct-to-consumer genetic tests. 
Given the lack of clear benefits of DTC genetic tests to the 
general  population,  educational  interventions  should  be 
developed to increase awareness and specific knowledge 
regarding the appropriate use of DTC genetic tests among 
people who are already aware of their existence.
Introduction
With the completion of the Human Genome Project (1), 
genetic  tests  have  increasingly  become  available  to  the 
population. Genetic testing is defined as “the analysis of 
human DNA, RNA, chromosomes, proteins, and certain 
metabolites  in  order  to  detect  heritable  disease-related 
genotypes, mutations, phenotypes, or karyotypes for clini-
cal  purposes”  (2).  Genetic  tests  that  target  specific  dis-
eases, such as cancer, are offered in health care settings 
to identify people with increased disease risk, for example, 
because  of  family  history  (3).  The  American  Society  of 
Clinical  Oncology  recognizes  that  identifying  people  at 
highest risk for cancer may improve prevention and early 
detection efforts and therefore supports access to genetic 
testing for all people with apparent heredity risk for can-
cer (4). In addition, the general public, patient groups, and 
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people with a family history of cancer (5-7) appear to be 
strongly interested in genetic testing.
Despite increasing availability and public interest, stud-
ies on genetic testing are few, and most have focused on 
specific cancer types, as disease-specific tests have become 
more  available  in  recent  years.  Previous  research  sug-
gests that not all sociodemographic groups have benefited 
equally from genetic counseling and testing for cancer sus-
ceptibility (8); their use has been documented to be lower 
among racial/ethnic minority populations compared with 
non-Hispanic  whites  (8,9).  Among  African  Americans, 
studies of diverse groups in the medical setting, includ-
ing women seeking general medical services (10), cancer 
patients (11), and people with a family history of cancer 
(12), have established consistently low levels of awareness 
of  genetic  testing  for  early  identification  of  cancer  risk 
compared  with  non-Hispanic  whites.  Although  studies 
of genetic testing specifically among Hispanics are few, 
analyses reveal low levels of awareness and use of genetic 
cancer screening (8,9,11), much of which has been shown 
to be related to education levels, nativity, or length of resi-
dence in the United States (8,13).
Genetic tests are increasingly being offered as direct-to-
consumer (DTC) services through the Internet and other 
venues,  providing  people  access  to  these  tests  without 
the involvement of a health care professional (14,15). For 
example,  nutrigenomic  testing,  which  involves  testing 
for genes associated with common diseases, is becoming 
increasingly  common;  these  results  are  used,  together 
with information on diet and lifestyle habits provided by 
the test subject, to assess potential health risks and inform 
recommendations  on  behavioral  changes,  diet,  or  nutri-
tional supplements (14-16). Of concern and of potential 
harm to consumers are 1) limited regulations and guide-
lines for pretest and posttest counseling, 2) inconsisten-
cies in the accreditation of the laboratories involved, and   
3)  inconsistencies  in  medical  advice  regarding  interpre-
tation  of  results  (14).  In  addition,  a  report  by  the  US 
Government Accountability Office (GAO) highlighted con-
cerns about nutrigenomic tests, stressing that such tests 
may  mislead  consumers  by  making  vague  predictions 
about their health risks (17). A more recent report from 
the GAO also highlights concerns about DTC genetic tests 
(18),  including  deceptive  marketing  of  the  capacities  of 
such tests, lack of standardization across companies, and 
erroneous advice, concluding that test results are mislead-
ing  and  of  little  use  to  consumers.  For  example,  given 
that companies test for different risk markers, different 
companies may provide different results regarding disease 
risk for the same person. In addition, because prevalence 
of genetic variants may differ by population or ancestry, it 
is not clear how different tests may benefit people from dif-
ferent racial/ethnic minority populations (18) or admixed 
populations, such as Puerto Ricans. Furthermore, the tests 
poorly predict disease risk and may not account for gene-
gene interactions and gene-environment interactions.
Demographic differences between people who are aware 
of  and  use  genetic  tests  have  been  observed  for  both 
DTC tests and for tests administered in clinical settings 
(13,14,19);  such  differences  may  contribute  to  health 
disparities among population subgroups. Information on 
public awareness, interest, or use of genetic tests is gener-
ally limited and is nonexistent for the population of Puerto 
Rico. This information is necessary to better understand 
public demand for these tests and will provide baseline 
data to track consumer awareness of and demand for DTC 
genetic tests. In addition, better knowledge is necessary 
to develop educational interventions, increase awareness, 
and improve decision making about these tests. Given the 
limited data on genetic testing among Hispanic popula-
tions and the lack of data for Puerto Rico, our study aimed 
to determine the prevalence and correlates of DTC genetic 
test awareness and the prevalence of genetic test use in a 
population-based sample of adults surveyed for the Health 
Information National Trends Survey (HINTS) conducted 
in Puerto Rico in 2009.
Methods
Study design and study population
We performed a secondary data analysis from a sample 
of adults aged 18 years or older who participated in the 
cross-sectional 2009 HINTS survey conducted in Puerto 
Rico (HINTS-PR). Data collection procedures for the 2009 
HINTS-PR survey have been described in detail elsewhere 
(20). In brief, the 2007-2008 HINTS survey used for the 
mainland HINTS data collection (21) was fielded in Puerto 
Rico from April to June 2009, through the Puerto Rico 
Behavioral  Risk  Factor  Surveillance  System  telephone 
research center. Data were collected via random-digit dial-
ing and a computer-assisted telephone interview system; 
the  stratified  sampling  frame  represented  8  geographic 
regions  designated  by  the  Puerto  Rico  Department  of 
Health. Within each stratum, sampled telephone numbers 
were  selected  with  equal  probability.  Nonworking  and VOLUME 8: NO. 5
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nonresidential numbers were eliminated from the sample. 
Trained  bilingual  Puerto  Rican  interviewers  collected 
639 interviews from 837 households screened (weighted 
extended  interview  response  rate,  76%).  Of  these,  611 
respondents (96%) provided complete information on DTC 
test awareness and were included in our analysis. All of 
these 611 respondents also had complete information on 
age and sex, and although 2 were missing information on 
genetic test use, their data were retained for the study.
The main outcome variables included in our analysis were 
awareness of DTC genetic tests and use of genetic tests, 
assessed with the following questions: “Genetic tests that 
analyze your DNA, diet, and lifestyle for potential health 
risks are currently being marketed by companies directly 
to consumers. Have you heard or read about these genetic 
tests?”  and  “Have  you  ever  had  a  genetic  test?”  Study 
covariates included demographic characteristics such as 
age, sex, education, marital status, and employment sta-
tus. Information on health insurance coverage and person-
al and family history of cancer was also assessed. Other 
covariates  of  interest  included  body  mass  index,  daily 
consumption of 5 or more servings of fruit or vegetables, 
and having a regular health care provider. Current smok-
ers were defined as people who had smoked at least 100 
cigarettes in their lifetime and continued to smoke at the 
time of the interview. 
We  also  assessed  information  about  health,  cancer- 
specific information seeking, and sources of information. 
Respondents were asked, “Have you ever looked for infor-
mation about health or medical topics from any source?” 
and “Have you ever looked for cancer information from any 
source?” Respondents who sought health or cancer infor-
mation were asked to identify the source: “The most recent 
time you looked for information about health or medical 
topics, where did you go first?” Responses were categorized 
into 4 groups: Internet, printed materials (eg, brochures, 
pamphlets, newspapers, books), health care professionals, 
and other (eg, interpersonal contact, TV, radio, telephone, 
health organizations).
Data analysis
All analyses were weighted to estimate standard errors 
of point estimates for the complex survey data by using 
jackknife repetition as an estimator. Data were weighted 
according  to  total  estimates  of  sex,  age,  education,  and 
marital status obtained from the American Community 
Survey  for  Puerto  Rico  (20)  to  provide  representative 
estimates of the adult population in Puerto Rico. We cal-
culated descriptive statistics for all variables included in 
this analysis. We conducted bivariate analysis to assess 
potential associations between demographic, health, and 
behavioral characteristics of respondents and awareness 
of genetic tests by using the Pearson χ2 test. On the basis 
of the results of the bivariate analysis, we constructed a 
multivariate  logistic  regression  model  to  estimate  odds 
ratios  and  their  95%  confidence  intervals  for  the  asso-
ciation  between  covariates  of  interest  and  genetic  test 
awareness. Interactions and goodness of fit of the model 
were tested with the likelihood ratio test and the Hosmer-
Lemeshow test, respectively.
Results
The  majority  of  respondents  (56%)  were  aware  of  DTC 
genetic tests, and approximately 4% had ever used any 
genetic test (Table 1). Lower awareness of DTC genetic 
tests was observed among men, single people, smokers, 
and people who had never sought health or cancer infor-
mation (Table 2). Among people who were aware of genetic 
tests (n = 361), those who had ever looked for cancer infor-
mation (n = 122) sought this information mostly via the 
Internet (47%), printed materials (28%), or through health 
care providers (16%). A similar pattern was observed for 
general health information seeking (data not shown).
We  found  no  significant  interactions  in  the  multivari-
ate model and a good model fit (Hosmer-Lemeshow test: 
χ2 = 2.50; P = .96). Awareness of DTC genetic tests was 
independently  associated  with  marital  status:  people 
who were married or living together and those who were 
divorced, separated, or widowed were more likely to be 
aware of genetic tests than people who were never mar-
ried. Current smokers were less likely than nonsmokers to 
be aware of genetic tests, and respondents who had ever 
looked  for  cancer  information  were  more  likely  to  have 
heard or read about DTC genetic tests than those who had 
not (Table 3).
Discussion
Although our result for awareness of DTC genetic tests 
(56%) was higher than that reported in the United States 
in the 2006 HealthStyles Survey (14%) and for Hispanic 
(25%)  and  non-Hispanic  (30%)  respondents  in  the  2008 
US  HINTS  (overall  prevalence,  29%)  using  the  same   VOLUME 8: NO. 5
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survey item (14,22,23), the lack of awareness in our sam-
ple was nevertheless high. Meanwhile, use of genetic tests 
in Puerto Rico (4%) was higher than that reported in the 
United States by the 2006 HealthStyles National Survey 
1%, but lower than that reported in the 2008 US HINTS 
survey overall 8% and for Hispanic 9% and non-Hispanic 
respondents 8%. Although causal attributions cannot be 
established  from  these  data,  the  higher  awareness  and 
use of genetic testing observed in Puerto Rico relative to 
mainland estimates coincides with more marketing and 
availability of such tests over time (24).
Similar to what has been seen in the US mainland (14), 
instead of health care professionals, the Internet was the 
primary source of information for DTC tests in our study. 
This source of information is of concern because a system-
atic analysis of websites promoting nutrigenomic services 
in 2006 showed that organizations that either sold or pro-
moted these tests did not provide adequate information 
about nutrigenomic services and at-home genetic testing 
in terms of laboratory certifications, test validity or utility, 
or genetic counseling (16).
Even though this lack of professional information could 
be because limited data are available to support the prod-
ucts currently on the market (14), the rapid growth in the 
availability of health-related DTC genetic tests offers an 
opportunity for professional organizations to develop and 
promote their posture regarding the use of these tests and 
highlights the need for the development of consistent rec-
ommendations (15); these measures will support the tests’ 
appropriate use as more data become available. Clinicians 
should advise their patients that currently available test-
ing  has  little  value  for  disease  risk  ascertainment  but 
should  use  the  opportunity  to  direct  patient  counseling 
toward modifiable risk factors, such as tobacco cessation 
(25). Government regulation regarding the use of these 
technologies will also be essential (26).
Consistent with the results of our study, previous research 
from  US  HINTS  has  identified  a  positive  relationship 
between  health  information  seeking  and  genetic  test 
awareness (23). Whereas, although the 2006 HealthStyles 
data revealed a higher prevalence of genetic test awareness 
among respondents younger than 65 years and those with 
at least a high school education, neither age nor education 
were associated with awareness of genetic tests in Puerto 
Rico.  Neither  our  study  nor  the  study  by  Goddard  and 
colleagues (14) identified significant associations between 
sex or family history of cancer and test awareness. Similar 
results have been observed for Hispanics in the 2000 and 
2005  National  Health  Interview  Survey,  specifically  for 
genetic testing for increased cancer risk (13,27). However, 
these  findings  are  inconsistent  with  research  reporting 
more awareness and use of genetic tests among women 
and people with a family history of cancer (5-9). For family 
history, the lack of association could be explained by the 
low proportion of people in our study with family history of 
cancer (low statistical power). Meanwhile, the association 
between smoking status and awareness of DTC genetic 
tests is particularly interesting given that this group is at 
an increased risk of multiple chronic diseases and could be 
a group that benefits from DTC testing in the future, if the 
benefit of testing is established.
Health  disparities  exist  in  cancer  occurrence  by  race/ 
ethnicity (28). Some of these disparities may be explained 
by  differences  in  lifestyle  and  environmental  or  genetic 
risk factors across populations. Although we do not focus 
our analysis on genetic testing specifically for cancer risk, 
genetic cancer screening may provide needed motivation 
and  opportunities  for  prevention  because  people  with 
basic knowledge about inherited cancer risk and aware-
ness of genetic testing for cancer susceptibility mutations 
may make more informed choices about their health care 
services (27). Although Puerto Ricans living in the United 
States  show  the  highest  level  of  awareness  of  genetic 
testing for cancer risk compared with other Hispanic sub-
groups (13,27), socioeconomic and racial/ethnic disparities 
in use of genetic counseling and testing for cancer suscep-
tibility continue to exist (8,9,19). One explanation for the 
lower awareness and use of genetic tests for cancer risk in 
racial/ethnic minority populations, particularly Hispanics, 
is that they are less exposed to health information through 
the health care system partially because of language bar-
riers  (8).  Low  awareness  about  genetic  testing  among 
Hispanics may increase cancer disparities in this group 
(29). Thus, to guard against the possibility of tests becom-
ing  a  source  of  health  disparity  (29),  DTC  and  cancer- 
specific genetic tests that have proven health benefits in 
the future should be made equally available to all who 
might benefit from them.
Our study is subject to limitations. First, because HINTS-
PR was a telephone-based survey, it includes data only 
from  residents  who  have  a  working  landline  telephone. 
Consequently, our data may not be generalizable to the 
entire  adult  Puerto  Rican  population.  Nonetheless,  the 
weighted  extended  interview  response  rate  in  the  2009 
HINTS-PR  (76.4%)  was  higher  than  that  reported  for VOLUME 8: NO. 5
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the 2007 US HINTS (60.4%) (30). Second, the prevalence 
estimates were based on self-reported information, which 
is subject to recall and social desirability biases. Third, the 
small number of respondents who had used genetic tests 
did not permit us to explore correlates of this behavior. 
Finally, our estimates of awareness of DTC tests and use 
of genetic tests may be inaccurate if respondents did not 
fully understand or misinterpreted the study questions. In 
fact, even though the research question used to determine 
DTC genetic test awareness included a brief explanation 
of  these  tests,  some  people  may  not  understand  what 
a  genetic  test  is;  this  clarity  issue  should  be  carefully 
addressed in future studies.
To our knowledge, this study provides the first published 
data on the awareness of DTC genetic tests and use of 
genetic tests in Puerto Rico. These baseline data are valu-
able for tracking trends in awareness of DTC tests and use 
of genetic tests in Puerto Rico and can inform the develop-
ment of policy and educational efforts regarding the appro-
priate use of these tests. We expect that the proportion of 
people who are aware of and use these tests will continue 
to increase, as more of these tests become available, as 
their marketing increases, and as the Internet and other 
sources of information become more widely available to 
the general population. Given the lack of clear benefits of 
DTC genetic tests to the general population, educational 
interventions should be developed to increase awareness 
and specific knowledge regarding the appropriate use of 
DTC genetic tests among people who are already aware 
of their existence (primary audience). As a clear message 
about these tests is in circulation, people who are unaware 
(secondary audience) may start to become more adequate-
ly aware of them. Future studies should try to elucidate 
remaining questions in this area of genetic testing, such as 
the prevalence of disease-specific genetic testing in clinical 
settings, and other psychosocial correlates of genetic test-
ing awareness, including attitudes, beliefs, and cultural or 
religious norms regarding their use.
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Characteristic n % (95% CI)a
Sex
Female 29 52.9 (51.-5.5)
Male 182 .1 (5.5-8.)
Age, y
18-9 115 9.9 (.5-.)
0-59 191 5.2 (1.-9.2)
≥60 05 2.9 (2.0-2.)
Marital statusb
Single, never married 11 1. (2.-5.1)
Married/living together 0 9.0 (5.5-52.)
Separated/widowed/divorced 10 19.9 (1.0-2.2)
Educationc
Less than high school diploma 1 2.5 (18.-28.)
High school/vocational diploma 1 2.0 (2.-.)
College or more 259 .5 (0.8-8.)
Employedb
Yes 1 0.2 (5.-.)
No 29 59.8 (55.-.)
Characteristic n % (95% CI)a
Have health insurance coverage
Yes 582 9.0 (90.1-95.8)
No 29 .0 (.2-9.9)
Body mass index, kg/m2 d
<25.0 (underweight/normal) 212 .8 (29.-9.8)
25.0-29.9 (overweight) 19 1.8 (2.8-.9)
≥30.0 (obese) 1 . (2.9-8.8)
Current smokere
Yes 128 1.9 (12.-21.)
No  8.1 (8.-8.)
Heard of direct-to-consumer genetic testsf
Yes 1 55.8 (8.-.2)
No 250 .2 (.8-51.)
Ever had a genetic testg
Yes 25 . (1.-.0)
No 58 95. (9.0-98.)
Tables
Table 1. Characteristics, Awareness of Direct-to-Consumer Genetic Tests, and Use of Genetic Tests Among Puerto Rican Adults (n = 
611), Health Information National Trends Survey, 2009
Abbreviation: CI, confidence interval. 
a Percentages are weighted. 
b 18 missing values. 
c 21 missing values. 
d 1 missing values. 
e 9 missing values. 
f Standard error = .8 using jackknife repetition as an estimator. 
g 2 missing values. Standard error = 1. using jackknife repetition as an estimator.VOLUME 8: NO. 5
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Table 2. Prevalence of Direct-to-Consumer Genetic Test Awareness, by Selected Characteristics, Among Puerto Rican Adults (n = 
611), Health Information National Trends Survey, 2009
Characteristic
Test Awareness
P Valueb na % (95% CI)
Sex
Female 2 . (55.8-0.)
.01
Male 95 . (5.-58.9)
Age, y
18-9 9 5.1 (.0-8.)
.8 0-59 11 5. (2.8-.)
≥60 15 5.5 (50.-2.)
Marital status
Single, never married  .1 (5.-59.0)
.0 Married/living together 188 5.9 (8.-5.)
Separated/widowed/divorced 100 . (5.-.9)
Education
<High school 8 5. (.-.)
.1 High school/vocational diploma 91 .8 (.5-0.0)
College or more 1 .2 (52.0-.)
Employed
Yes 10 5. (2.1-.)
.9
No 28 5.5 (8.-.)
Have health insurance coverage
Yes 5 55.8 (8.1-.5)
.98
No 1 55.5 (25.-85.)
Personal history of cancer
Yes 28 .0 (.2-8.8)
.25
No 22 55.2 (.-.0)
Family history of cancer
Yes 228 5.8 (9.5-.1)
.
No 122 51.8 (0.1-.5)
Body mass index, kg/m2
<25.0 (underweight/normal) 10 1.2 (50.8-1.)
.0 25.0-29.9 (overweight) 119 55.5 (.8-.2)
≥30.0 (obese) 9 50. (.9-2.9)
 
Abbreviation: CI, confidence interval. 
a Not all categories add to total for awareness (n = 1) because of missing values. 
b Calculated by using the Pearson χ2 test.
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Characteristic
Test Awareness
P Valueb na % (95% CI)
Current smoker
Yes 2 2.9 (.0-52.8)
.02
No 282 58.0 (9.-.)
Have regular health care provider
Yes 292 58. (50.-.0)
.20
No 9 8.5 (.-2.)
≥5 Servings fruits or vegetables daily
Yes 0 0. (.8-2.)
.9
No 291 5.9 (.2-2.)
Ever looked for information on health topics
Yes 150 .0 (5.9-.2)
.00
No 211 50.2 (1.-59.1)
Ever looked for cancer information
Yes 122 2.0 (1.2-82.)
.001
No 29 50.2 (0.8-58.)
 
Abbreviation: CI, confidence interval. 
a Not all categories add to total for awareness (n = 1) because of missing values. 
b Calculated by using the Pearson χ2 test.
Table 2. (continued) Prevalence of Direct-to-Consumer Genetic Test Awareness, by Selected Characteristics, Among Puerto Rican 
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Table 3. Odds of Genetic Testing Awareness, by Demographic Characteristics, Among Puerto Rican Adults, Health Information 
National Trends Survey, 2009
Characteristic Odds Ratio (95% CI)
Sex
Male 1 [Reference]
Female 1.1 (0.9-2.50)
Age, y
18-9 1 [Reference]
0-59 0.81 (0.-1.)
≥60 0.99 (0.5-1.8)
Marital status
Single, never married 1 [Reference]
Separated/widowed/divorced 2. (1.0-5.2)
Married/living together 1. (1.02-.0)
Ever looked for information on health topics
No 1 [Reference]
Yes 1. (0.90-2.8)
Ever looked for cancer information
No 1 [Reference]
Yes 2.0 (1.0-.9)
Current smoking
No 1 [Reference]
Yes 0.52 (0.2-0.8)
 
Abbreviation: CI, confidence interval.